The Care Home Independent Pharmacist Prescriber Study (CHIPPS): development and implementation of an RCT to estimate safety, effectiveness and cost-effectiveness
Programme Grants for Applied Research · 2023
DOI: 10.3310/jbpt2117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Programme Grants for Applied Research, 2023. Verfasst von David Wright und 29 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
Background
Medicine prescribing, monitoring and administration in care homes can be significantly enhanced. Effective interventions to improve pharmaceutical care and resident outcomes are required. The enablement of pharmacists to prescribe provides an opportunity for pharmacist independent prescribers to assume responsibility for improving pharmaceutical care, medication-related outcomes and resident safety whilst reducing general practitioner workload. Objective(s) To determine the effectiveness and cost-effectiveness of pharmacist independent prescribing in care homes.
Design
Development work was undertaken through five work packages before the delivery of the definitive trial. Triads of pharmacist independent prescribers, care home and general practice with responsibility over 20 care home residents were recruited and cluster randomised to intervention or usual care for 6 months. Researchers were blinded at recruitment stage only. Recruitment of 880 residents was required to provide 80% statistical power, to show a 21% reduction in falls over 6 months, assuming 20% attrition. Randomisation was undertaken electronically at triad level, stratified by geographical area. Intention-to-treat analysis undertaken using a negative binomial model. Parameters were estimated using a generalised estimating equation approach. Costs were captured from an NHS perspective. Quality of life (EuroQol; five domain; five level) was collected by proxy to enable cost/quality-adjusted life-year estimation. A concurrent process evaluation was performed. Safety was monitored through a review of pharmacist independent prescriber activities, independent concerns reporting and review of adverse events.
Participants
Forty-nine triads of general practitioners, pharmacist independent prescribers and care homes were recruited with 454 residents allocated to the intervention arm and 428 to the control arm.
Intervention
Medication review and care planning, medication reconciliation, staff training, support with care home medication-related procedures, deprescribing and authorisation of monthly prescriptions. Main outcome measure Fall rate per person over 6 months.
Results
Data for 449 intervention and 427 control residents available for final analysis. The 6-month fall rate ratio in favour of intervention was 0.91 (95% confidence interval 0.66 to 1.26; p =0.58). No significant difference in secondary outcomes was identified except Drug Burden Index (rate ratio 0.83, 95% confidence interval 0.75 to 0.92; p
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Wright, D., Holland, R., Alldred, D. P., Bond, C., Hughes, C., Barton, G., Poland, F., Shepstone, L., Arthur, A., Birt, L., Blacklock, J., Blyth, A., Cheilari, S., Daffu-O’Reilly, A., Dalgarno, L., Desborough, J., Ford, J., Grant, K., Gray, J., …, & Zermansky, A. (2023). The Care Home Independent Pharmacist Prescriber Study (CHIPPS): development and implementation of an RCT to estimate safety, effectiveness and cost-effectiveness. Programme Grants for Applied Research. https://doi.org/10.3310/jbpt2117
Vancouver
Wright D, Holland R, Alldred DP, Bond C, Hughes C, Barton G, et al. The Care Home Independent Pharmacist Prescriber Study (CHIPPS): development and implementation of an RCT to estimate safety, effectiveness and cost-effectiveness. Programme Grants for Applied Research. 2023. doi:10.3310/jbpt2117
BibTeX
@article{Wright2023,
author = {Wright, David and Holland, Richard and Alldred, David Phillip and Bond, Christine and Hughes, Carmel and Barton, Garry and Poland, Fiona and Shepstone, Lee and Arthur, Antony and Birt, Linda and Blacklock, Jeanette and Blyth, Annie and Cheilari, Stamatina and Daffu-O’Reilly, Amrit and Dalgarno, Lindsay and Desborough, James and Ford, Joanna and Grant, Kelly and Gray, Janet and Handford, Christine and Harry, Bronwen and Hill, Helen and Inch, Jacqueline and Myint, Phyo Kyaw and Norris, Nigel and Spargo, Maureen and Maskrey, Vivienne and Turner, David and Watts, Laura and Zermansky, Arnold},
title = {The Care Home Independent Pharmacist Prescriber Study (CHIPPS): development and implementation of an RCT to estimate safety, effectiveness and cost-effectiveness},
journal = {Programme Grants for Applied Research},
year = {2023},
doi = {10.3310/jbpt2117}
}
EUVIMED